The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...

With new treatments and maybe even a vaccine on the horizon, 2025 could be an important year for improving the lives of ...

Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

The post appears to reference the drug lenacapavir, which reportedly can cost around $40,000 annually in the U.S. and is administered in twice-yearly doses. While the drug appears to be effective ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases, offering hope to patients with limited alternatives. A significant breakthrough in treating the Human Immunodeficiency ...

This year we saw more examples of the destructive effort to undermine abortion as a health service. But overreach into health practices was not limited to abortion care.

Uganda is registering around 38,000 new infections despite the deployment of different interventions such as condoms and oral ...

ATLANTA - Lenacapavir, a new injectable drug for HIV prevention, is being hailed by Emory University medical experts as a breakthrough in the fight against the virus. The drug offers a long-acting ...